Ranking reactive glutamines in the fibrinogen αC region that are targeted by blood coagulant factor XIII

作者: Kelly Njine Mouapi , Jacob D. Bell , Kerrie A. Smith , Robert A. S. Ariëns , Helen Philippou

DOI: 10.1182/BLOOD-2015-09-672303

关键词:

摘要: Factor XIIIa (FXIIIa) introduces covalent γ-glutamyl-e-lysyl crosslinks into the blood clot network. These involve both γ and α chains of fibrin. The C-terminal portion fibrin chain extends αC region (210-610). Crosslinks within this help generate a stiffer clot, which is more resistant to fibrinolysis. Fibrinogen (233-425) contains binding site for FXIIIa three glutamines Q237, Q328, Q366 that each participate in physiological crosslinking reactions. Although these were previously identified, their reactivities toward have not been ranked. Matrix-assisted laser desorption/ionization time flight (MALDI-TOF) mass spectrometry nuclear magnetic resonance (NMR) methods thus used directly characterize probe sources substrate specificity. Glycine ethyl ester (GEE) ammonium chloride served as replacements lysine. Mass 2D heteronuclear single quantum coherence NMR revealed Q237 rapidly crosslinked first by followed Q328. Both (15)NH4Cl (15)N-GEE could be with similar order reactivity observed MALDI-TOF assay. studies using mutants Q237N, Q328N, Q366N demonstrated no glutamine dependent on another react series. Moreover, remaining two mutant still reactive. Further characterization important because they are located fibrinogen susceptible truncations mutation. current results suggest play distinct roles architecture.

参考文章(60)
Tatiana P. Ugarova, Roman Safiullin, Wayne Christenson, Hadil Owaynat, Ivan S. Yermolenko, Marsil K. Kadirov, Robert Ros, Fibrinogen matrix deposited on the surface of biomaterials acts as a natural anti-adhesive coating. Biomaterials. ,vol. 67, pp. 151- 159 ,(2015) , 10.1016/J.BIOMATERIALS.2015.07.007
Martin L. Schwartz, Salvatore V. Pizzo, Robert L. Hill, Patrick A. McKee, Human Factor XIII from Plasma and Platelets MOLECULAR WEIGHTS, SUBUNIT STRUCTURES, PROTEOLYTIC ACTIVATION, AND CROSS-LINKING OF FIBRINOGEN AND FIBRIN Journal of Biological Chemistry. ,vol. 248, pp. 1395- 1407 ,(1973) , 10.1016/S0021-9258(19)44312-3
S. N. P. Murthy, J. H. Wilson, T. J. Lukas, Y. Veklich, J. W. Weisel, L. Lorand, Transglutaminase-catalyzed crosslinking of the Aα and γ constituent chains in fibrinogen Proceedings of the National Academy of Sciences of the United States of America. ,vol. 97, pp. 44- 48 ,(2000) , 10.1073/PNAS.97.1.44
P J Coussons, N C Price, S M Kelly, B Smith, L Sawyer, Transglutaminase catalyses the modification of glutamine side chains in the C-terminal region of bovine beta-lactoglobulin. Biochemical Journal. ,vol. 283, pp. 803- 806 ,(1992) , 10.1042/BJ2830803
Cédric Duval, Peter Allan, Simon D. A. Connell, Victoria C. Ridger, Helen Philippou, Robert A. S. Ariëns, Roles of fibrin α- and γ-chain specific cross-linking by FXIIIa in fibrin structure and function Thrombosis and Haemostasis. ,vol. 111, pp. 842- 850 ,(2014) , 10.1160/TH13-10-0855
HELEN RITCHIE, LAURA C. LAWRIE, MICHAEL W. MOSESSON, NUALA A. BOOTH, Characterization of crosslinking sites in fibrinogen for plasminogen activator inhibitor 2 (PAI-2). Annals of the New York Academy of Sciences. ,vol. 936, pp. 215- 218 ,(2006) , 10.1111/J.1749-6632.2001.TB03508.X
Laszlo Lorand, Robert M. Graham, Transglutaminases: crosslinking enzymes with pleiotropic functions Nature Reviews Molecular Cell Biology. ,vol. 4, pp. 140- 156 ,(2003) , 10.1038/NRM1014
Esther A. Ryan, Lyle F. Mockros, Andrew M. Stern, Laszlo Lorand, Influence of a Natural and a Synthetic Inhibitor of Factor XIIIa on Fibrin Clot Rheology Biophysical Journal. ,vol. 77, pp. 2827- 2836 ,(1999) , 10.1016/S0006-3495(99)77114-6